Themis Medicare Share Price

₹ 100.88

+₹6.05 (6.38%)
1D
Last updated 02 Nov, 2026, 15:56 IST
NSE: THEMISMED
|
Pharmaceuticals

Themis Medicare Share Price Today

As of 2 Nov 2026, Themis Medicare share price is ₹100.88. The stock opened at ₹95.10, compared to its previous close of ₹94.83. During today's trading session, Themis Medicare share price moved in the range of ₹95.05 to ₹101.88, with an average price of ₹98.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹64.95 and a high of ₹140.60. On the performance front, Themis Medicare share price has declined by 3.92% over the last six months and is down 23.88% on a year-on-year basis.

Share price over the last 1 day rose from 95.05 to 101.19, ranging between 95.05 and 101.50.
₹95.05
6.38% up today
₹101.88
1D LOW
1D HIGH

Themis Medicare Stock Insights

Latest Earning
Op Profit TrendUp by 326.05% QoQ
Latest Earning
Net Profit TrendUp by 176.83% QoQ
Latest Earning
Revenue TrendUp by 9.66% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 13.68 % in last 1 yr
Shareholding Pattern
FIIFII increased stake by 6.25%
Themis Medicare stock performance
Open₹95.10
High₹101.88
Low₹95.05
Prev. close₹94.83
Themis Medicare trading activity
Volume33,958
Average traded price₹100.16
Last traded time03:56:05 02 Nov
Last traded quantity200
Circuit
L
H
₹75.87
₹113.79
52-week
L
H
₹64.95
₹140.60
Mkt Cap Cr
874.95
P/E
21.89
P/B
2.39
ROA
6.68%
ROE
0.42%
ROCE
2.7%
Quick Ratio
1.35
EV/EBITDA
12.67

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Themis Medicare has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Themis Medicare appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Themis Medicare earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Themis Medicare Company Background

ISIN
INE083B01024
Sector Market Cap
₹ 874.95 Cr

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.

Themis Medicare Financial Highlights

  • Revenue: Themis Medicare reported revenue of ₹351.60 crore in FY26 vs ₹410.18 crore in FY25. It showed a decrease of 14.28% on a yearly basis.
  • Operating Profit: Themis Medicare reported an operating profit of ₹1.93 crore in FY26 vs ₹39.67 crore in FY25. It showed a decrease of 95.13% on a year-on-year basis.
  • Net Profit: Themis Medicare reported a net profit of ₹1.14 crore in FY26 vs ₹29.83 crore in FY25. It showed a decrease of 96.18% on a yearly basis.

Themis Medicare Quarterly Result Highlights

  • Themis Medicare reported revenue of ₹87.95 crore in Jun 2026, compared with ₹80.20 crore in Mar 2026, representing an increase of 9.66% on a quarter-on-quarter (QoQ) basis.
  • Themis Medicare reported an operating profit of ₹38.60 crore in Jun 2026, compared with ₹9.06 crore in Mar 2026, representing an increase of 326.05% on a quarter-on-quarter (QoQ) basis.
  • Themis Medicare reported a profit of ₹24.61 crore in Jun 2026, compared with ₹8.89 crore in Mar 2026, reflecting an increase of 176.83% on a QoQ basis.
  • The earnings per share (EPS) of Themis Medicare stood at ₹0.12 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
67.11%
FII
0.01%
Other DII
0.01%
Retail and other
32.87%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.05%
Mar 20260.11%
Jun 20260.01%
Sep 20260.01%

Themis Medicare Investment Returns

1 day
-2.76%
1 week
+4.51%
1 month
-18.57%
1 year
-23.88%
3 years
-37.41%
5 years
+15.83%

Themis Medicare Share Price History

Themis Medicare share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹97.39 / ₹94.83
-2.76%
29 Oct 26
₹100.45 / ₹97.52
-0.93%
28 Oct 26
₹95.00 / ₹98.44
+2.83%
27 Oct 26
₹92.64 / ₹95.73
+4.77%
Show more

Themis Medicare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹342.24₹405.51₹381.76₹354.32
Other Income₹9.36₹4.67₹4.76₹11.50
Total Revenue₹351.60₹410.18₹386.52₹365.83
Total Expenses₹362.85₹376.43₹351.88₹306.93
Profit Before Tax₹1.93₹39.67₹53.44₹72.51
Tax₹0.78₹9.84₹9.92₹15.61
Profit After Tax₹1.14₹29.83₹43.52₹56.90
EPS - Basic₹0.12₹3.24₹4.73₹6.18
EPS - Diluted₹0.12₹3.24₹4.72₹6.17

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1.93₹39.67₹53.44₹72.51
Income before WC changes₹5.18₹50.57₹51.97₹72.54
Change in Assets-₹3.16-₹14.31-₹31.83-₹56.66
Change in Liabilities₹1.12₹9.20₹10.91₹16.36
Change in WC-₹2.04-₹5.11-₹20.92-₹40.30
Cash flow from Operations-₹3.27₹34.71₹22.09₹16.09
Cash flow from Investing-₹2.54-₹12.17-₹15.95-₹23.96
Cash flow from Financing₹3.79-₹25.90-₹8.77₹0.14
Total Cash Flow-₹2.02-₹3.36-₹2.62-₹7.73
Cash (Start of the year)₹6.56₹9.92₹12.55₹20.28
Cash (End of the year)₹4.54₹6.56₹9.92₹12.55

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹292.93₹284.17₹273.25₹249.43
Current Assets₹304.98₹303.87₹293.17₹264.53
Total Assets₹597.91₹588.03₹566.42₹513.96
Current Liabilities₹166.16₹156.12₹154.58₹139.13
Net Current Asset₹138.82₹147.74₹138.58₹125.40
Non-Current Liabilities₹33.17₹29.31₹34.17₹35.39
Equity Capital₹398.58₹402.60₹377.67₹339.44
Total Equity & Liabilities₹597.91₹588.03₹566.42₹513.96

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹342.24₹405.51₹381.76₹354.32
Other Income₹9.36₹4.67₹4.76₹11.50
Total Revenue₹351.60₹410.18₹386.52₹365.83
Total Expenses₹362.84₹376.42₹351.85₹306.92
Profit Before Tax-₹13.40₹33.76₹34.67₹58.91
Tax₹0.78₹9.84₹9.92₹15.61
Profit After Tax-₹14.19₹23.92₹24.75₹43.29
EPS - Basic-₹1.54₹2.60₹2.69₹4.70
EPS - Diluted-₹1.54₹2.59₹2.68₹4.70

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹13.40₹33.76₹34.67₹58.91
Income before WC changes₹3.90₹50.58₹51.99₹72.57
Change in Assets-₹1.89-₹14.32-₹31.89-₹56.68
Change in Liabilities₹1.12₹9.20₹10.91₹16.34
Change in WC-₹0.77-₹5.12-₹20.99-₹40.34
Cash flow from Operations-₹3.27₹34.71₹22.04₹16.07
Cash flow from Investing-₹2.54-₹12.17-₹15.96-₹23.96
Cash flow from Financing₹3.79-₹25.90-₹8.77₹0.14
Total Cash Flow-₹2.02-₹3.36-₹2.68-₹7.75
Cash (Start of the year)₹6.47₹9.83₹12.51₹20.27
Cash (End of the year)₹4.45₹6.47₹9.83₹12.51

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹195.22₹200.50₹195.52₹190.49
Current Assets₹304.99₹305.15₹294.44₹265.80
Total Assets₹500.21₹505.65₹489.97₹456.29
Current Liabilities₹166.10₹156.06₹152.92₹139.07
Net Current Asset₹138.90₹149.09₹141.52₹126.72
Non-Current Liabilities₹33.17₹29.31₹35.77₹35.39
Equity Capital₹300.95₹320.29₹301.28₹281.83
Total Equity & Liabilities₹500.21₹505.65₹489.97₹456.29
* All values are in INR Crore
Themis Medicare market depth
Bid quantityBid priceAsk priceAsk quantity
00100.88262
0000
0000
0000
0000
Total bid quantity0
Total ask quantity262
Themis Medicare technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
33.6
Neutral
ATR (14)
6.44
Neutral
STOCH(9,6)
28.39
Neutral
STOCH RSI (14)
76.08
Neutral
ADX(9)
40.43
Bearish
UO(9)
37.36
Neutral
ROC(12)
-11.14
Bearish
WillR(14)
-73.92
Neutral
Period
Simple value
Exponential vaue
5D
95.58
96.06
10D
96.62
97.85
20D
103.34
102.54
50D
114.32
108.93
100D
112.29
108.82
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Themis Medicare
Pharmaceuticals
Add Stock
Add Another

Themis Medicare Share Price FAQs

Please be aware that Themis Medicare stock prices are subject to continuous fluctuations due to various factors.